AlpVision and ISID Partner in Anti-Counterfeit Technology

Published: August 01, 2016

VEVEYK SWITZERLAND | AlpVision, a supplier of digital invisible technologies for product authentication and counterfeit protection, has signed a distribution contract for its Cryptoglyph technology with Japanese IT and consulting service provider Information Services International-Dentsu (ISID). “ISID is a natural fit to support the development of the Japanese market and to help with the deployment of our Cryptoglyph technology, particularly on pharmaceutical packaging,” says Martin Kutter, president of AlpVision.

AlpVision says that in partnering with ISID, it not only hopes to respond to the increasing number of counterfeit Japanese brand-name pharmaceuticals sold in foreign countries but also of fake medications appearing on the Japanese market.

“Japanese pharmaceutical companies represent approximately 20% of the worldwide pharmaceutical turnover and offer interesting development perspectives for AlpVision,” says AlpVision CEO Fred Jordan. "The expansion of our business in Japan is as much a reflection of the increasing need for our services as it is of the continuing growth we’re experiencing in East Asia."

Printed using offset, flexographic, and rotogravure printing presses, AlpVision Cryptoglyph is said to be invisible to the naked eye and can be detected using a smartphone. Company says the technology has been deployed among the Fortune 200 pharmaceutical companies in the world for more than a decade.

This email address is being protected from spambots. You need JavaScript enabled to view it.